Spondylodiscitis complicating infective endocarditis.


Journal

Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087

Informations de publication

Date de publication:
12 2020
Historique:
received: 28 12 2019
revised: 20 04 2020
accepted: 20 04 2020
pubmed: 30 5 2020
medline: 30 6 2021
entrez: 30 5 2020
Statut: ppublish

Résumé

The primary objective was to assess the characteristics and prognosis of pyogenic spondylodiscitis (PS) in patients with infective endocarditis (IE). The secondary objectives were to assess the factors associated with occurrence of PS. Prospective case-control bi-centre study of 1755 patients with definite IE with (n=150) or without (n=1605) PS. Clinical, microbiological and prognostic variables were recorded. Patients with PS were older (mean age 69.7±18 vs 66.2±14; p=0.004) and had more arterial hypertension (48% vs 34.5%; p<0.001) and autoimmune disease (5% vs 2%; p=0.03) than patients without PS. The lumbar vertebrae were the most frequently involved (84 patients, 66%), especially L4-L5. Neurological symptoms were observed in 59% of patients. Enterococci and PS is a frequent complication of IE (8.5% of IE), is observed in older hypertensive patients with enterococcal or

Identifiants

pubmed: 32467102
pii: heartjnl-2019-316492
doi: 10.1136/heartjnl-2019-316492
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1914-1918

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Andreina Carbone (A)

Cardiology Department, APHM, La Timone Hospital, Marseille, France.

Audrey Lieu (A)

Pôle Coeur-Thorax-Vaisseaux, Department of Cardiology, University Hospital Amiens, Amiens, France.
Research Unity 2 EA 7517, MP3CV, Jules Verne University of Picardie, Amiens, France.

Basile Mouhat (B)

Cardiology Department, APHM, La Timone Hospital, Marseille, France.

Francesco Santelli (F)

Department of Social Sciences, University Federico II, Naples, Italy.

Mary Philip (M)

Cardiology Department, APHM, La Timone Hospital, Marseille, France.

Yohann Bohbot (Y)

Pôle Coeur-Thorax-Vaisseaux, Department of Cardiology, University Hospital Amiens, Amiens, France.
Research Unity 2 EA 7517, MP3CV, Jules Verne University of Picardie, Amiens, France.

Laetitia Tessonnier (L)

Department of Nuclear Medicine, La Timone Hospital, Marseille, France.

Fanny Peugnet (F)

Pôle Coeur-Thorax-Vaisseaux, Department of Cardiology, University Hospital Amiens, Amiens, France.
Research Unity 2 EA 7517, MP3CV, Jules Verne University of Picardie, Amiens, France.

Antonello D'Andrea (A)

Luigi Vanvitelli University-Naples, Monaldi Hospital, Naples, Italy.
Dipartimento di Scienze Cardio-Toraciche e Respiratorie, Università degli Studi della Campania "Luigi Vanvitelli, Naples, Italy.

Serge Cammilleri (S)

Department of Nuclear Medicine, La Timone Hospital, Marseille, France.

Quentin Delpierre (Q)

Pôle Coeur-Thorax-Vaisseaux, Department of Cardiology, University Hospital Amiens, Amiens, France.
Research Unity 2 EA 7517, MP3CV, Jules Verne University of Picardie, Amiens, France.

Frédérique Gouriet (F)

URMITE, Aix Marseille Université, UM63, CNRS 7278, IRD 198, INSERM 1095-IHU, Marseille, France.
Aix Marseille University, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.

Laurence Camoin-Jau (L)

Aix Marseille University, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
Department of Hematology, La Timone Hospital, Marseille, France.

Mesut Gun (M)

Pôle Coeur-Thorax-Vaisseaux, Department of Cardiology, University Hospital Amiens, Amiens, France.
Research Unity 2 EA 7517, MP3CV, Jules Verne University of Picardie, Amiens, France.

Jean-Paul Casalta (JP)

URMITE, Aix Marseille Université, UM63, CNRS 7278, IRD 198, INSERM 1095-IHU, Marseille, France.
Aix Marseille University, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.

Alberto Riberi (A)

Department of Cardiac surgery, La timone Hospital, Marseille, France.

Frederic Collart (F)

Cardiology Department, APHM, La Timone Hospital, Marseille, France.

Hélène Martel (H)

Cardiology Department, APHM, La Timone Hospital, Marseille, France.

Florent Arregle (F)

Cardiology Department, APHM, La Timone Hospital, Marseille, France.

Eric Guedj (E)

Department of Nuclear Medicine, La Timone Hospital, Marseille, France.

Didier Raoult (D)

URMITE, Aix Marseille Université, UM63, CNRS 7278, IRD 198, INSERM 1095-IHU, Marseille, France.
Aix Marseille University, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.

Michel Drancourt (M)

URMITE, Aix Marseille Université, UM63, CNRS 7278, IRD 198, INSERM 1095-IHU, Marseille, France.
Aix Marseille University, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.

Christophe Tribouilloy (C)

Pôle Coeur-Thorax-Vaisseaux, Department of Cardiology, University Hospital Amiens, Amiens, France.
Research Unity 2 EA 7517, MP3CV, Jules Verne University of Picardie, Amiens, France.

Gilbert Habib (G)

Cardiology Department, APHM, La Timone Hospital, Marseille, France gilbert.habib3@gmail.com.
Aix Marseille University, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH